Trial Profile
Influence of resistance factors on efficacy of sitagliptine in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Feb 2016 New trial record
- 12 Jan 2016 Results published in the Clinical Therapeutics